Skip to main content

Table 1 Gender, age, administration period, DM, and MRONJ staging of each group

From: Evaluation of mandibular cortical bone ratio on computed tomography images in patients taking bisphosphonates

 

Group A

(n = 33)

Group B

(n = 30)

Group C

(n = 32)

Gender

Male

3

2

9

Female

30

28

23

DM

Presence

8

4

8

Absence

25

26

24

Age

Years (mean ± SD)

74.5 ± 6.0

74.3 ± 5.8

74.8 ± 5.1

65 ≤ years < 75 (n)

21

15

17

75 ≤ years < 85 (n)

11

14

15

85 ≤ years (n)

1

1

0

Administration period (n = 49)

Years (mean ± SD)

6.3 ± 5.3

4.8 ± 4.4

< 4 years (n)

10

12

≥ 4 years (n)

15

12

MRONJ Staging

Stage 1

1

Stage 2

27

Stage 3

5

  1. A: patients with MRONJ
  2. B: patients taking BP without MRONJ
  3. C: controls